Monitoring Agency Report for the quarter ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings Limited, the monitoring agency, submitted its Q4FY26 report for a preferential issue of Rs. 218.70 crore (originally Rs. 1,028.70 crore but undersubscribed). Of the Rs. 160.38 crore received so far, Rs. 115.64 crore has been deployed across working capital (Rs. 81.82 crore), investments in subsidiaries/CCPS (Rs. 76.44 crore including Rs. 30.82 crore in Q4 to Brij Gopal Construction via Sneha Garg and Just Right Life), and minor issue expenses. The MA flagged limited traceability of working capital funds due to commingling across accounts and inability to verify Ebix transactions. Multiple material concerns were noted: a UK High Court case over USD 40 million FCCB proceeds (pending), an ED raid on promoter Vikas Garg linked to a money-laundering investigation, completed arbitration with Vikas Lifecare (settled via 51% Ebix UK transfer), qualified auditor opinion on undisclosed related party transactions, and consistent quarterly net losses since Q4 FY25.
The filing reveals significant governance, legal, and financial risks — including a sub-judice FCCB dispute, Enforcement Directorate scrutiny of the promoter, and unresolved related-party transaction compliance — which could materially damage investor confidence and the company's financial position. The share price being below the warrant exercise price also raises risk of warrant lapse.